The expression of FOXL1 in subepithelial or intestinal stem cells may contribute to CRC (59).The current research does not determine whether there are distinct CAF subtypes that play tumor-promoting and -suppressive roles. This evidence concerns the gene FOXL1 and colorectal carcinoma.